Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia

被引:97
作者
Dallaire, F [1 ]
Ouellet, N [1 ]
Bergeron, Y [1 ]
Turmel, V [1 ]
Gauthier, MC [1 ]
Simard, M [1 ]
Bergeron, MG [1 ]
机构
[1] Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada
关键词
D O I
10.1086/322021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pneumococcal pneumonia still is associated with a high mortality rate, despite appropriate antimicrobial therapy. Many gaps remain in the understanding of the pathogenesis of this deadly infection. The microbial and inflammatory events that characterize survival or death after intranasal inoculation of mice with an LD50 inoculum of Streptococcus pneumoniae were investigated. Survival was associated with rapid bacterial clearance and low inflammation (surfactant and red blood cells in alveoli), but no neutrophil recruitment or lung tissue injury was noted. By contrast, death was preceded by strong bacterial growth that peaked 48 h after the infection and was associated with gradual increases in pulmonary levels of interleukin-6, macrophage inflammatory protein (MIP)-1 alpha, MIP-2, monocyte chemoattractant protein-1, KC, and neutrophil recruitment. The injection of tumor necrosis factor-alpha or the addition of lipopolysaccharide or heat-killed S. pneumoniae to the inoculum enhanced early host response and survival. These observations may help develop appropriate markers of evolution of pneumonia, as well as new therapeutic strategies.
引用
收藏
页码:292 / 300
页数:9
相关论文
共 30 条
[1]   STREPTOCOCCUS-PNEUMONIAE - VIRULENCE FACTORS, PATHOGENESIS, AND VACCINES [J].
ALONSODEVELASCO, E ;
VERHEUL, AFM ;
VERHOEF, J ;
SNIPPE, H .
MICROBIOLOGICAL REVIEWS, 1995, 59 (04) :591-&
[2]   DEGRADATION OF C3 BY STREPTOCOCCUS-PNEUMONIAE [J].
ANGEL, CS ;
RUZEK, M ;
HOSTETTER, MK .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :600-608
[3]   SUBCELLULAR-DISTRIBUTION OF DAPTOMYCIN GIVEN ALONE OR WITH TOBRAMYCIN IN RENAL PROXIMAL TUBULAR CELLS [J].
BEAUCHAMP, D ;
GOURDE, P ;
SIMARD, M ;
BERGERON, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) :189-194
[4]   Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice [J].
Bergeron, Y ;
Ouellet, N ;
Deslauriers, AM ;
Simard, M ;
Olivier, M ;
Bergeron, MG .
INFECTION AND IMMUNITY, 1998, 66 (03) :912-922
[5]   PNEUMOCOCCAL PROTEINS AND THE PATHOGENESIS OF DISEASE CAUSED BY STREPTOCOCCUS-PNEUMONIAE [J].
BOULNOIS, GJ .
JOURNAL OF GENERAL MICROBIOLOGY, 1992, 138 :249-259
[6]   MEASUREMENT OF CUTANEOUS INFLAMMATION - ESTIMATION OF NEUTROPHIL CONTENT WITH AN ENZYME MARKER [J].
BRADLEY, PP ;
PRIEBAT, DA ;
CHRISTENSEN, RD ;
ROTHSTEIN, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 78 (03) :206-209
[7]   The molecular basis of pneumococcal infection: A hypothesis [J].
Cundell, D ;
Masure, HR ;
Tuomanen, EI .
CLINICAL INFECTIOUS DISEASES, 1995, 21 :S204-S212
[8]   Efficacy of recombinant human granulocyte colony-stimulating factor in a murine model of pneumococcal pneumonia: Effects of lung inflammation and timing of treatment [J].
Dallaire, F ;
Ouellet, N ;
Simard, M ;
Bergeron, Y ;
Bergeron, MG .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (01) :70-77
[9]   COMPARTMENTALIZED CYTOKINE PRODUCTION WITHIN THE HUMAN LUNG IN UNILATERAL PNEUMONIA [J].
DEHOUX, MS ;
BOUTTEN, A ;
OSTINELLI, J ;
SETA, N ;
DOMBRET, MC ;
CRESTANI, B ;
DESCHENES, M ;
TROUILLET, JL ;
AUBIER, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (03) :710-716
[10]  
Dinarello CA, 1997, J BIOL REG HOMEOS AG, V11, P91